Lawrence S Gaines1,2, James C Slaughter3, Sara N Horst1, David A Schwartz1, Dawn B Beaulieu1, Kirsten L Haman2, Li Wang3, Christopher F Martin4, Millie D Long4, Robert S Sandler4, Michael D Kappelman5. 1. Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, Vanderbilt University Medical Center, Nashville, Tennessee, USA. 2. Department of Psychiatry, Vanderbilt University Medical Center, Nashville, Tennessee, USA. 3. Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA. 4. Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. 5. Department of Pediatrics, Division of Pediatric Gastroenterology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Abstract
OBJECTIVES: The prevalence of depression is high in patients with Crohn's disease (CD). We examined the influence of affective-cognitive symptoms of depression on the risk of exacerbation of CD. METHODS: We studied 2,144 adult volunteers with a self-reported diagnosis of CD who completed a baseline survey that included demographics, CD status, and an affective-cognitive index of depression. Linear and logistic regression analyses were used to determine whether CD status at 12 months was associated with the baseline measure of depression. Analyses were adjusted for confounders including age, gender, race, baseline disease activity, disease duration, prior hospitalization and surgery, corticosteroid and anti-TNF use, medication adherence, body mass index, current smoking, education, and sleep quality. RESULTS: Depression was significantly associated with subsequent increases in SCDAI score in both unadjusted (P<0.001) and adjusted (P<0.001) analyses. This association was non-linear, with a shallower slope for lower levels of depression. A 10-point increase in depression t-scores from 55 to 65 was associated with a 18.6-point increase in SCDAI (95% CI 11.5-25.6) and an odds ratio of 1.27 for SCDAI>150 at follow-up (CI: 1.01-1.60). We also found a significant association between depressive symptoms and hospitalization. CONCLUSIONS: Cognitive-affective depressive symptoms were significantly associated with a risk of exacerbation of CD and hospitalization.
OBJECTIVES: The prevalence of depression is high in patients with Crohn's disease (CD). We examined the influence of affective-cognitive symptoms of depression on the risk of exacerbation of CD. METHODS: We studied 2,144 adult volunteers with a self-reported diagnosis of CD who completed a baseline survey that included demographics, CD status, and an affective-cognitive index of depression. Linear and logistic regression analyses were used to determine whether CD status at 12 months was associated with the baseline measure of depression. Analyses were adjusted for confounders including age, gender, race, baseline disease activity, disease duration, prior hospitalization and surgery, corticosteroid and anti-TNF use, medication adherence, body mass index, current smoking, education, and sleep quality. RESULTS:Depression was significantly associated with subsequent increases in SCDAI score in both unadjusted (P<0.001) and adjusted (P<0.001) analyses. This association was non-linear, with a shallower slope for lower levels of depression. A 10-point increase in depression t-scores from 55 to 65 was associated with a 18.6-point increase in SCDAI (95% CI 11.5-25.6) and an odds ratio of 1.27 for SCDAI>150 at follow-up (CI: 1.01-1.60). We also found a significant association between depressive symptoms and hospitalization. CONCLUSIONS: Cognitive-affective depressive symptoms were significantly associated with a risk of exacerbation of CD and hospitalization.
Authors: Millie D Long; Michael D Kappelman; Christopher F Martin; James D Lewis; Lloyd Mayer; Patricia M Kinneer; Robert S Sandler Journal: Inflamm Bowel Dis Date: 2012-01-27 Impact factor: 5.325
Authors: P Persoons; S Vermeire; K Demyttenaere; B Fischler; J Vandenberghe; L Van Oudenhove; M Pierik; T Hlavaty; G Van Assche; M Noman; P Rutgeerts Journal: Aliment Pharmacol Ther Date: 2005-07-15 Impact factor: 8.171
Authors: Eva M Szigethy; Ada O Youk; David Benhayon; Diane L Fairclough; Melissa C Newara; Margaret A Kirshner; Simona I Bujoreanu; Christine Mrakotsky; Athos Bousvaros; Arvind I Srinath; David J Keljo; David J Kupfer; David R DeMaso Journal: J Pediatr Gastroenterol Nutr Date: 2014-05 Impact factor: 2.839
Authors: Christian Mittermaier; Clemens Dejaco; Thomas Waldhoer; Anna Oefferlbauer-Ernst; Wolfgang Miehsler; Markus Beier; Wolfgang Tillinger; Alfred Gangl; Gabriele Moser Journal: Psychosom Med Date: 2004 Jan-Feb Impact factor: 4.312
Authors: Clarence K Zhang; Jennifer Hewett; Jason Hemming; Taneisha Grant; Hongyu Zhao; Clara Abraham; Ioannis Oikonomou; Meera Kanakia; Judy H Cho; Deborah D Proctor Journal: Inflamm Bowel Dis Date: 2013-07 Impact factor: 5.325
Authors: Ashwin N Ananthakrishnan; Hamed Khalili; An Pan; Leslie M Higuchi; Punyanganie de Silva; James M Richter; Charles S Fuchs; Andrew T Chan Journal: Clin Gastroenterol Hepatol Date: 2012-08-31 Impact factor: 11.382
Authors: Jörg Wiltink; Matthias Michal; Philipp S Wild; Astrid Schneider; Jochem König; Maria Blettner; Thomas Münzel; Andreas Schulz; Matthias Weber; Christian Fottner; Norbert Pfeiffer; Karl Lackner; Manfred E Beutel Journal: PLoS One Date: 2014-08-15 Impact factor: 3.240
Authors: Lawrence S Gaines; James C Slaughter; David A Schwartz; Dawn B Beaulieu; Sara N Horst; Robin L Dalal; Elizabeth A Scoville; Robert S Sandler; Michael D Kappelman Journal: Inflamm Bowel Dis Date: 2020-02-11 Impact factor: 5.325
Authors: Bharati Kochar; Christopher F Martin; Michael D Kappelman; Brennan M Spiegel; Wenli Chen; Robert S Sandler; Millie D Long Journal: Am J Gastroenterol Date: 2017-08-29 Impact factor: 10.864
Authors: Gary R Lichtenstein; Edward V Loftus; Kim L Isaacs; Miguel D Regueiro; Lauren B Gerson; Bruce E Sands Journal: Am J Gastroenterol Date: 2018-03-27 Impact factor: 10.864
Authors: Edward L Barnes; Millie D Long; Michael D Kappelman; Christopher F Martin; Robert S Sandler Journal: Inflamm Bowel Dis Date: 2019-06-18 Impact factor: 5.325